HMTLY yields 0.75% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, HMTLY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMTLY + JNJ for your $10,000?
Hitachi Metals, Ltd. manufacture and sell specialty steel products, functional components and equipment, magnetic materials and applications/power electronics materials, wires and cables, and related products in Japan, North America, Asia, Europe, and internationally. The company's Specialty Steel Products segment offers molds and tool steels, rolls for steel mills, injection molding machine parts, structural ceramic products, and steel-frame joints for construction; automobile-related materials, razor and blade materials, precision cast components, and aircraft- and energy-related materials; and display-related materials, semiconductor and other package materials, and battery-related materials. Its Functional Components and Equipment segment provides HNM ductile cast iron products, cast iron products for transportation equipment, heat-resistant exhaust casting components, and Aluminum components; and piping and infrastructure components. The company's Magnetic Materials and Applications/Power Electronics Materials segment offers rare-earth magnets, ferrite magnets, and other magnets and applied products; and amorphous metals, nanocrystalline magnetic materials, soft ferrite, and applied products, as well as ceramic components. Its Wires, Cables, and Related Products segment provides industrial cables, electronic wires, electric equipment materials, cable assemblies, and industrial rubber products; and automotive electronic components and brake hoses. The company was founded in 1910 and is headquartered in Tokyo, Japan. Hitachi Metals, Ltd. is a subsidiary of Hitachi, Ltd.
Full HMTLY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.